BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1362837)

  • 1. Folinic acid rescue used routinely in psoriatic patients with known methotrexate "sensitivity".
    Hills RJ; Ive FA
    Acta Derm Venereol; 1992 Nov; 72(6):438-40. PubMed ID: 1362837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate supplementation during methotrexate therapy for patients with psoriasis.
    Strober BE; Menon K
    J Am Acad Dermatol; 2005 Oct; 53(4):652-9. PubMed ID: 16198787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.
    Prey S; Paul C
    Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of psoriasis with methotrexate and folinic acid.
    Burkhart CG
    J Am Acad Dermatol; 1980 Aug; 3(2):207-8. PubMed ID: 6967877
    [No Abstract]   [Full Text] [Related]  

  • 5. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Ghogomu ET; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.
    Baran W; Batycka-Baran A; Zychowska M; Bieniek A; Szepietowski JC
    Expert Opin Drug Saf; 2014 Aug; 13(8):1015-21. PubMed ID: 24972718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the appropriate dosage of folinic acid after high-dose methotrexate for childhood acute lymphatic leukemia that will prevent neurotoxicity without rescuing malignant cells in the central nervous system.
    Cohen IJ
    J Pediatr Hematol Oncol; 2004 Mar; 26(3):156-63. PubMed ID: 15125607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
    Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose methotrexate with folinic acid rescue.
    Bender JF; Grove WR; Fortner CL
    Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
    Cansu DÜ; Teke HÜ; Bodakçi E; Korkmaz C
    Clin Rheumatol; 2018 Dec; 37(12):3419-3425. PubMed ID: 30056523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid.
    Joyce DA; Will RK; Hoffman DM; Laing B; Blackbourn SJ
    Ann Rheum Dis; 1991 Dec; 50(12):913-4. PubMed ID: 1768158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent use of folinic acid and methotrexate in rheumatoid arthritis.
    Hanrahan PS; Russell AS
    J Rheumatol; 1988 Jul; 15(7):1078-80. PubMed ID: 3050087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.
    Buckley LM; Vacek PM; Cooper SM
    J Rheumatol; 1990 Sep; 17(9):1158-61. PubMed ID: 2132565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials.
    Ortiz Z; Shea B; Suarez-Almazor ME; Moher D; Wells GA; Tugwell P
    J Rheumatol; 1998 Jan; 25(1):36-43. PubMed ID: 9458200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue after intermediate and high-dose methotrexate: background, rationale, and current practice.
    Borsi JD; Sagen E; Romslo I; Moe PJ
    Pediatr Hematol Oncol; 1990; 7(4):347-63. PubMed ID: 2268535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of folates concomitantly with low-dose pulse methotrexate.
    Shiroky JB
    Rheum Dis Clin North Am; 1997 Nov; 23(4):969-80. PubMed ID: 9361164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of folinic acid on low-dose methotrexate genotoxicity.
    Shahin AA; Ismail MM; Saleh AM; Moustafa HA; Aboul-Ella AA; Gabr HM
    Z Rheumatol; 2001 Apr; 60(2):63-8. PubMed ID: 11383050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of folinic acid on hepatoma cells containing methotrexate polyglutamates.
    Galivan J; Nimec Z
    Cancer Res; 1983 Feb; 43(2):551-5. PubMed ID: 6184149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pancytopenia during low-dose oral methotrexate therapy of psoriatic arthritis].
    Kohler S; Neumann J; Dürk H; Saal J; Müller GA
    Dtsch Med Wochenschr; 1989 Aug; 114(34):1286-8. PubMed ID: 2766951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folinic acid to prevent side effects of methotrexate in juvenile rheumatoid arthritis.
    Alarcón GS; Morgan SL
    J Rheumatol; 1996 Dec; 23(12):2184-5. PubMed ID: 8970066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.